佛跳墙vnpAndroid版

We’re Horizon, a global biopharmaceutical company driven by a simple idea: we believe that science and compassion must work together to transform lives.

Our pipeline is built on purpose, and our scientific courage drives us to tackle many marginalized, overlooked or forgotten diseases.

At Horizon, we’re driven by a clear purpose; to improve patients’ lives. And the clearest expression of that purpose is the portfolio of medicines we offer to treat rare and rheumatic diseases.

As a company, we condemn racism in all its abhorrent forms, including anti-Black racism and stand in solidarity with our Black colleagues and Black communities around the country. Read our statement here.

07/31/2020 New Topline TEPEZZA® (teprotumumab-trbw) Data Underscore its Efficacy in Longer Disease Duration, Long-Term Durability and Potential for Retreatment in People Living with Thyroid Eye Disease (TED) 07/22/2020 Target Enrollment Reached in MIRROR Randomized Controlled Trial Evaluating KRYSTEXXA® (pegloticase injection) Co-Prescribed with Methotrexate as an Immunomodulator to Enhance Response Rates for People Living with Uncontrolled Gout